Cognition Therapeutics, Inc. Public Float
Cognition Therapeutics, Inc. (CGTX) had Public Float of $18.16 million as of 2025-06-30, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-26
- 2025-06-30: Entity Public Float $18.16M.
- 2024-06-30: Entity Public Float $56.31M.
- 2023-06-30: Entity Public Float $43.12M.
- 2022-06-30: Entity Public Float $38.23M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $18.16M 10-K · filed 2026-03-26 |
| 2024-06-30 | $56.31M 10-K · filed 2025-03-20 |
| 2023-06-30 | $43.12M 10-K · filed 2024-03-26 |
| 2022-06-30 | $38.23M 10-K · filed 2023-03-23 |
| 2021-12-31 | $81.36M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |